Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.
Winkelmayer
Wolfgang C
WC
Tonelli
Marcello
M
D000085:Acetates; D017610:Calcium Compounds; D002614:Chelating Agents / Q000627:therapeutic use*; D015312:Hemodialysis Solutions; D006801:Humans; D054559:Hyperphosphatemia / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000628:therapy*; D009398:Nephrology; D011073:Polyamines / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians'; D006435:Renal Dialysis; D012107:Research Design; D000069603:Sevelamer
D000085:Acetates; D017610:Calcium Compounds; D002614:Chelating Agents; D015312:Hemodialysis Solutions; D011073:Polyamines; D000069603:Sevelamer; C120662:calcium acetate